Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Integr Cancer Ther ; 7(3): 139-46, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18815145

ABSTRACT

OBJECTIVES: Cancer survivors often turn to religion, spirituality, and complementary and alternative medicine (CAM) because they perceive these areas as being more holistic and patient-centered than conventional medicine. Because increased religiosity and spirituality have been found to be associated with higher CAM use in the general population, it was hypothesized that these factors would be important predictors of CAM use in cancer survivors. DESIGN AND SUBJECTS: The study included a subsample of 1844 people with cancer or a history of cancer from the 2003 California Health Interview Survey of CAM, a cross-sectional survey of a population-based sample of adults in California. Prevalence and predictors of religious/spiritual forms of CAM (R/S CAM) and nonreligious/nonspiritual forms of CAM (non-R/S CAM) were compared. Multivariate logistic regression was used to identify the predictors of R/S CAM and non-R/S CAM. RESULTS: Nearly two thirds of participants reported using at least 1 type of R/S CAM, and 85% reported ever using non-R/S CAM. The majority of cancer survivors reported that they were very/moderately religious or spiritual. Both religiosity and spirituality were strongly related to non-R/S CAM use, but in opposite directions. Very or moderately religious cancer survivors were less likely (odds ratio=0.30; 95% confidence interval, 0.12-0.40) than nonreligious cancer survivors to use non-R/S CAM. In contrast, very or moderately spiritual cancer survivors were more likely (odds ratio=2.42; 95% confidence interval, 1.16-6.02) than nonspiritual cancer survivors to use non-R/S CAM. CONCLUSIONS: The use of R/S CAM and non-R/S CAM is very high in cancer survivors. It may be helpful for clinicians to ascertain their patients' use of these types of CAM to integrate all forms of care used to managing their cancer.


Subject(s)
Complementary Therapies/statistics & numerical data , Neoplasms/therapy , Religion and Medicine , Spirituality , Adult , Aged , California/epidemiology , Complementary Therapies/psychology , Cross-Sectional Studies , Female , Health Surveys , Humans , Logistic Models , Male , Middle Aged , Multivariate Analysis , Neoplasms/psychology , Survivors/psychology , Young Adult
2.
Clin Nephrol ; 67(4): 255-9, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17474563

ABSTRACT

We report a case of tubulointerstitial nephritis and uveitis (TINU syndrome) with full type Fanconi syndrome. A 32-year-old woman presented with fatigue, anorexia and weight loss. Laboratory findings showed anemia, polyclonal hypergammaglobulinemia and moderate renal dysfunction. Tubular function abnormalities were normoglycemic glucosuria, panaminoaciduria, phosphaturia and kaliuresis leading to hypokalemia. Renal tubular acidosis and hypouricemia were also evident. Serum antistreptolysin O titer was high. Ocular symptoms (bilateral anterior uveitis) emerged soon after admission. Renal biopsy showed diffuse tubulointerstitial infiltration by lymphocytes and plasma cells without granuloma. Treatment with systemic steroids was given and renal function, and ocular symptom returned to normal with 3 months. Although tubular abnormalities involving TINU syndrome has already been reported, the disease associated with full type Fanconi syndrome has rarely been seen, and systemic steroid may be beneficial in reducing the development of tubulointerstitial injury.


Subject(s)
Fanconi Syndrome/diagnosis , Nephritis, Interstitial/diagnosis , Uveitis/diagnosis , Acute Disease , Adult , Anti-Inflammatory Agents/therapeutic use , Diagnosis, Differential , Fanconi Syndrome/complications , Fanconi Syndrome/drug therapy , Female , Humans , Nephritis, Interstitial/complications , Nephritis, Interstitial/drug therapy , Prednisolone/therapeutic use , Uveitis/complications , Uveitis/drug therapy
3.
J Altern Complement Med ; 12(10): 1003-10, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17212572

ABSTRACT

OBJECTIVES: Acculturation and access to conventional health care have been found to be predictors of complementary and alternative medicine (CAM) use in the general population. We hypothesized that these factors would be predictors of CAM use in Asian-American subgroups. Because of differences in health and cultural beliefs, we also hypothesized that patterns and predictors of CAM use would vary among Asian-American subgroups. METHODS: Cross-sectional survey of a sample of 9187 adults representative of the California population. RESULTS: Nearly three quarters of Asian-Americans used at least one type of CAM in the past 12 months, which was significantly higher than the national prevalence rate. Chinese Americans had the highest prevalence of any CAM use, whereas South Asians had the lowest prevalence (86% vs. 67%, respectively). Acculturation and access to conventional medical care was unrelated to any CAM use for most Asian-American subgroups. Spirituality was the strongest predictor of any CAM use for most Asian-American subgroups. CONCLUSIONS: CAM use varies across Asian-American subgroups. Acculturation and access to conventional medical care is unrelated to any CAM use for most Asian-American subgroups.


Subject(s)
Acculturation , Asian/statistics & numerical data , Complementary Therapies/statistics & numerical data , Patient Acceptance of Health Care/statistics & numerical data , Adult , Aged , Attitude to Health/ethnology , Cross-Sectional Studies , Cultural Characteristics , Female , Humans , Male , Middle Aged , Patient Acceptance of Health Care/ethnology , Prevalence , Surveys and Questionnaires
4.
Breast Cancer ; 6(3): 227-30, 1999.
Article in English | MEDLINE | ID: mdl-18843552

ABSTRACT

A rare case of breast cancer associated with von Recklinghausen's neurofibromatosis is reported. This case and review of the literature illustrate the problems of clinical diagnosis.A 66-year-old woman who had undergone sigmoidectomy for sigmoid colon cancer two years previously, was admitted to the hospital because of a left breast skin retraction in October, 1998. The patient had von Recklinghausen's disease (neurofibromatosis type 1). The TNM clinical staging was TlcNOMO. Modified radical mastectomy was performed. The histopathological diagnosis of the breast tumor was invasive ductal carcinoma and the skin tumor was neurofibroma. The pTNM pathological staging was pTlcNlaMO.Among patients similar to our case, almost all were staged higher than T2. This may be because multiple neurofibromas obscure breast mass at palpation, leading to delayed detection of the cancer. Systemic and careful exploration is essential for patients with von Recklinghausen's neurofibromatosis to detect breast cancer at an early stage.

5.
Int Surg ; 85(4): 277-80, 2000.
Article in English | MEDLINE | ID: mdl-11589591

ABSTRACT

AIM: We examined the indication of upper mediastinal lymphadenectomy for a squamous cell carcinoma of the lower thoracic oesophagus. METHODS: 49 patients underwent a curative oesophagectomy with upper mediastinal lymphadenectomy for a squamous cell carcinoma of the lower thoracic oesophagus. Node status and clinicopathological characteristics of these patients were reviewed retrospectively. RESULTS: 16 (94.1%) of 17 patients with superficial tumours had no positive node in the upper mediastinum. Nine (29.0%) of 31 patients with transmural tumours had positive nodes in the upper mediastinum (P = 0.04). Ten (20.4%) of 49 patients had many positive nodes in the upper mediastinum. Of these 10 patients, 6 patients had 5 or more positive nodes in all. The 5-year survival rate for patients with 5 or more positive nodes was 7.7%, which was significantly poorer than patients with 4 or fewer positive nodes. CONCLUSIONS: Upper mediastinal lymphadenectomy is unnecessary in most of the superficial squamous carcinomas of the lower thoracic oesophagus.


Subject(s)
Carcinoma, Squamous Cell/surgery , Esophageal Neoplasms/surgery , Lymph Node Excision/methods , Lymph Nodes/pathology , Lymph Nodes/surgery , Aged , Aged, 80 and over , Biopsy, Needle , Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/pathology , Esophageal Neoplasms/mortality , Esophageal Neoplasms/pathology , Female , Follow-Up Studies , Humans , Lymphatic Metastasis , Male , Mediastinum , Middle Aged , Neoplasm Staging , Probability , Retrospective Studies , Survival Rate , Treatment Outcome
6.
Rev. argent. reumatol ; 26(3): 19-26, 2015. ilus, tab
Article in Spanish | LILACS | ID: biblio-835806

ABSTRACT

El objetivo de este estudio piloto fue evaluar la correlación entre las evaluaciones clínicas, radiológica y ecográfica en pacientes con AR. Material y métodos: Estudio de corte transversal realizado en el marco de un taller de clinimetría y ecografía para médicos reumatólogos. Se incluyeron pacientes ≥ a 18 años de edad, con diagnóstico de AR. Los pacientes fueron evaluados a través de autocuestionarios validados: actividad de la enfermedad (RADAI), capacidad funcional (HAQ-A y HAQ-II) y RAPID-3; escala visual análoga (EVA) para dolor, evaluación global de la enfermedad y rigidez matinal (RM) y recuento articular (28) por dos médicos reumatólogos. Estos dos médicos también determinaron la evaluación global de la enfermedad de los pacientes (EVA). Se consignó valor de eritrosedimentación (ERS) dentro de la semana previa al examen. Se calculó el índice compuesto DAS28. Radiografías de manos y pies (en posición frente) efectuadas dentro de la semana previa al examen fueron leídas por otros dos médicos reumatólogos mediante método de Sharp modificado por van der Heijde (SvdH) y método SENS (Simplified Erosion and Narrowing Score). A todos los pacientes se les realizó ecografía articular Modo B y Doppler de poder (PD) de 12 por 5 médicos experimentados. Se determinó presencia de derrame de líquido sinovial (DS), hipertrofia sinovial (HS) y señal (PD). A la presencia de cada uno de estos hallazgos se les asignaba 1 punto y el índice ecográfico total resultaba de la suma de los puntos positivos (rango 0-36).


The aim of this pilot study was to evaluate the correlation betweenclinical, radiological and ultrasound assessments in patients withRA.Material and methods: Cross-sectional study conducted in theframework of a clinimetric and ultrasound workshop for rheumatologists.We included patients with rheumatoid arthritis (ACR1987) ≥ 18 years of age. Patients were evaluated using validatedquestionnaires: disease activity (RADAI), functional capacity (HAQ-Aand HAQ-II) and RAPID-3; visual analog scale (VAS) for pain, globalassessment of disease and morning stiffness (MS) and joint count(28) by two rheumatologists who also determined the global assessmentof the patient’s disease (VAS). Sedimentation rate (ESR)in the week before the exam was recorded. DAS28 composite indexwas calculated. Radiographs of hands and feet (front position) performedwithin one week before the examination were read by tworheumatologists using the Sharp method modified by van der Heijde(SvdH) and SENS (Simplified Erosion and Narrowing Score) method.All patients underwent joint ultrasonography B Mode and PowerDoppler (PD) of 12 joints by 5 experienced physicians. Presence ofeffusion of synovial fluid (SF), synovial hypertrophy (SH) and signal(PD) were determined. To the presence of each of these findingswere assigned 1 point and the total ultrasound index was the sumof the positive points (range 0-36).


Subject(s)
Humans , Arthritis, Rheumatoid , Radiography , Ultrasonography
8.
EMBO J ; 1(6): 755-9, 1982.
Article in English | MEDLINE | ID: mdl-6329702

ABSTRACT

We have physically characterised a deletion mutant of the R plasmid R100 which has lost all of the antibiotic resistances, including chloramphenicol resistance (Cmr), coded by its IS1-flanked r-determinant. The deletion was mediated by one of the flanking IS1 elements and terminates within the carboxyl terminus of the Cmr gene. DNA sequence analysis showed that the mutated gene would produce a protein 20 amino acids longer than the wild-type due to fusion with an open reading frame in the IS element. Surprisingly for a deletion mutation, rare, spontaneous Cmr revertants could be recovered. Two of the four revertants studied had frame shifts due to the insertion of a single AT base pair at the same position; the revertants would code for a protein five amino acids shorter than the wild-type. The other two revertants had acquired duplications of the 34-bp inverted terminal repeat sequences of the IS1 element and would direct the synthesis of a protein six amino acids longer than the wild-type. The reverted Cmr markers were still capable of transposition. These observations suggest a role for point mutations and small DNA rearrangements in the formation of new gene organisations produced by mobile genetic elements.


Subject(s)
Biological Evolution , Chromosome Deletion , DNA Transposable Elements , Escherichia coli/genetics , Mutation , R Factors , Base Sequence , Chloramphenicol/toxicity , DNA Restriction Enzymes , Drug Resistance, Microbial , Nucleic Acid Hybridization
9.
Eur J Haematol ; 57(5): 384-8, 1996 Nov.
Article in English | MEDLINE | ID: mdl-9003480

ABSTRACT

We serially determined serum erythropoietin (Epo) and the reticulocyte count in patients with various types of leukemia during chemotherapy. Serum Epo increased soon after the initiation of chemotherapy and decreased after the termination of therapy irrespective of the types of leukemia or treatment regimen. However, it did not stay at low level but fluctuated. The reticulocyte count, on the other hand, showed a transient rise while serum Epo level descended. The value of serum Epo when increased was higher than the value expected from hemoglobin concentration; this finding was similar to that in aplastic anemia. These results suggest that myelosuppression is a major factor for the increase in serum Epo level during leukemia chemotherapy.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Erythropoietin/blood , Leukemia/blood , Reticulocytes/pathology , Adult , Aged , Blood Cell Count , Female , Humans , Leukemia/drug therapy , Leukemia/pathology , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL